Seach Medical Group (XTAE:SEMG) Debt-to-EBITDA : 0.00 (As of . 20)

View and export this data going back to 1990. Start your Free Trial

What is Seach Medical Group Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Seach Medical Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₪0.00 Mil. Seach Medical Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₪0.00 Mil. Seach Medical Group's annualized EBITDA for the quarter that ended in . 20 was ₪0.00 Mil.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Seach Medical Group's Debt-to-EBITDA or its related term are showing as below:

XTAE:SEMG's Debt-to-EBITDA is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 1.69
* Ranked among companies with meaningful Debt-to-EBITDA only.

Seach Medical Group Debt-to-EBITDA Historical Data

The historical data trend for Seach Medical Group's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Seach Medical Group Debt-to-EBITDA Chart

Seach Medical Group Annual Data

Trend

Debt-to-EBITDA

Seach Medical Group Quarterly Data

Debt-to-EBITDA

Competitive Comparison of Seach Medical Group's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Seach Medical Group's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Seach Medical Group's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Seach Medical Group's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Seach Medical Group's Debt-to-EBITDA falls into.

Seach Medical Group Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Seach Medical Group's Debt-to-EBITDA for the fiscal year that ended in . 20 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(	+	)	/	N/A
	=	N/A

Seach Medical Group's annualized Debt-to-EBITDA for the quarter that ended in . 20 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(	+	)	/	0
	=	N/A

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (. 20) EBITDA data.

Seach Medical Group (XTAE:SEMG) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Seach Medical Group Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Seach Medical Group's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Seach Medical Group (XTAE:SEMG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Seach Medical Group Ltd (XTAE:SEMG) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sharf 23, PO Box 1074, Hod Hasharon, ISR, 45110

Website

http://www.seach.co.il

Seach Medical Group Ltd is engaged in growing medical cannabis strains. The medical cannabis, in its various forms, is supplied to patients with a medical marijuana. It offers a variety of strains and products suitable to all clients. The company develop new strains and products that are customized to respond to the needs of patients and doctors. The company operates at both ends of the value chain, on the one hand, propagation and cultivation of cannabis medical, and on the other hand, the distribution and sale of final products to end customers, and at the same time actively exports its products.

Seach Medical Group (XTAE:SEMG) Headlines

No Headlines